The year in biotech begins flush with cash


Last January, when thousands of biotechnology executives and investors flooded the annual J.P. Morgan Healthcare Conference, there was a tincture of anxiety amid the talk of breakthrough medicines and shrewd corporate partnerships. Donald Trump had just been elected president.



from Biotech News